Compare PFE & CVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PFE | CVS |
|---|---|---|
| Founded | 1849 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 105.1B |
| IPO Year | 2013 | 1994 |
| Metric | PFE | CVS |
|---|---|---|
| Price | $25.64 | $97.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 18 |
| Target Price | $29.29 | ★ $94.72 |
| AVG Volume (30 Days) | ★ 24.4M | 7.6M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.55% | 3.17% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.47 | ★ 2.30 |
| Revenue | $62,579,000,000.00 | ★ $402,067,000,000.00 |
| Revenue This Year | N/A | $2.36 |
| Revenue Next Year | N/A | $4.69 |
| P/E Ratio | $55.39 | ★ $41.71 |
| Revenue Growth | N/A | ★ 7.85 |
| 52 Week Low | $23.11 | $58.50 |
| 52 Week High | $28.75 | $98.43 |
| Indicator | PFE | CVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 67.05 |
| Support Level | $25.02 | $75.24 |
| Resistance Level | $25.99 | $98.43 |
| Average True Range (ATR) | 0.43 | 2.10 |
| MACD | 0.03 | -0.19 |
| Stochastic Oscillator | 29.73 | 99.22 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.